How French pet owners view and use CBD for dogs and cats

Abstract

This study explored pet owners' perceptions and use of cannabidiol (CBD) for dogs and cats in France, examining factors associated with CBD use and attitudes toward the product. A total of 2050 pet owners completed an online survey including demographic characteristics, pet health, knowledge, and attitudes toward CBD. Findings revealed that CBD use was not widespread but remained notable, with 29 % of dog owners and 13 % of cat owners reporting administration, rates lower than those reported in countries such as the United States, Canada, or Slovenia. Use was more prevalent among younger owners and those with prior personal experience of CBD or other alternative treatments. No significant difference was observed between urban and rural residents, likely due to widespread internet access facilitating information and online purchases. A higher proportion of dogs than cats received CBD, possibly due to the greater difficulty of administering oral substances to cats. Despite its relatively limited use, owners generally held positive views of CBD's safety and benefits. Longer durations of CBD administration were linked to higher satisfaction levels. Importantly, discussions with veterinarians were significantly associated with CBD use, and veterinary recommendation was reported as a strong motivator for purchase decisions. Behavioral issues and pain were the main reasons for CBD use across species. Limitations include potential selection bias, a strong sex imbalance that limits representativeness for male owners, and reliance on self-reported data without clinical confirmation. These findings underline the need for clearer regulations, enhanced veterinary education, and clinical trials to provide evidence-based guidance on CBD use in veterinary medicine.